149 related articles for article (PubMed ID: 29683119)
1. Let's Talk About Financial Toxicities.
Katz A
Oncol Nurs Forum; 2018 May; 45(3):281-282. PubMed ID: 29683119
[TBL] [Abstract][Full Text] [Related]
2. The financial hazard of personalized medicine and supportive care.
Carrera PM; Olver I
Support Care Cancer; 2015 Dec; 23(12):3399-401. PubMed ID: 26306523
[TBL] [Abstract][Full Text] [Related]
3. The cost of cancer care.
Gilbert H
Nurs Stand; 1999 Nov 10-16; 14(8):12. PubMed ID: 11096849
[No Abstract] [Full Text] [Related]
4. Financial savvy: the value of business acumen in oncology nursing.
Rishel CJ
Oncol Nurs Forum; 2014 May; 41(3):324-6. PubMed ID: 24769597
[TBL] [Abstract][Full Text] [Related]
5. Conducting economic evaluation based on basket clinical trial in the area of precision medicine.
Nosrati M; Nikfar S
Expert Rev Pharmacoecon Outcomes Res; 2021 Apr; 21(2):169-171. PubMed ID: 33356657
[No Abstract] [Full Text] [Related]
6. Financial Toxicity: Limitations and Challenges When Caring for Older Adult Patients With Cancer.
Davis ME; Fugett S
Clin J Oncol Nurs; 2018 Dec; 22(6):43-48. PubMed ID: 30452018
[TBL] [Abstract][Full Text] [Related]
7. The Use of Targeted Therapies for Precision Medicine in Oncology.
White Al-Habeeb N; Kulasingam V; Diamandis EP; Yousef GM; Tsongalis GJ; Vermeulen L; Zhu Z; Kamel-Reid S
Clin Chem; 2016 Dec; 62(12):1556-1564. PubMed ID: 27679436
[No Abstract] [Full Text] [Related]
8. Managed care "de-skills" the oncology nurse, ONS says. Oncology Nursing Society.
Volkers N
J Natl Cancer Inst; 1999 Jun; 91(12):997-8. PubMed ID: 10379960
[No Abstract] [Full Text] [Related]
9. Roche splashes $2.4 billion on Foundation Medicine's cancer platform.
Sheridan C
Nat Biotechnol; 2018 Sep; 36(9):779-780. PubMed ID: 30188548
[No Abstract] [Full Text] [Related]
10. Personalized cancer medicine--advances and socio-economic challenges.
Jackson DB; Sood AK
Nat Rev Clin Oncol; 2011 Oct; 8(12):735-41. PubMed ID: 21989071
[TBL] [Abstract][Full Text] [Related]
11. Let's talk about challenges surrounding addiction in cancer pain.
Brant JM
ONS News; 2006 Jan; 21(1):8-9. PubMed ID: 16438089
[No Abstract] [Full Text] [Related]
12. Effective Cost Conversations: Addressing Financial Toxicity and Cost-Related Health Literacy.
Edward J
Clin J Oncol Nurs; 2020 Apr; 24(2):209-213. PubMed ID: 32196003
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs.
Haslem DS; Van Norman SB; Fulde G; Knighton AJ; Belnap T; Butler AM; Rhagunath S; Newman D; Gilbert H; Tudor BP; Lin K; Stone GR; Loughmiller DL; Mishra PJ; Srivastava R; Ford JM; Nadauld LD
J Oncol Pract; 2017 Feb; 13(2):e108-e119. PubMed ID: 27601506
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Alternative Payment Models on Oncology Innovation and Patient Care.
Miller AM; Omenn GS; Kean MA
Clin Cancer Res; 2016 May; 22(10):2335-41. PubMed ID: 27087022
[TBL] [Abstract][Full Text] [Related]
15. Precision Medicine: Accelerating the Science to Revolutionize Cancer Care
.
Brant JM; Mayer DK
Clin J Oncol Nurs; 2017 Dec; 21(6):722-729. PubMed ID: 29149123
[TBL] [Abstract][Full Text] [Related]
16. Balancing the Economics and Ethics of Personalised Oncology.
Flaum N; Hall P; McCabe C
Trends Cancer; 2018 Sep; 4(9):608-615. PubMed ID: 30149879
[TBL] [Abstract][Full Text] [Related]
17. Budget impact and cost-effectiveness: can we afford precision medicine in oncology?
Doble B
Scand J Clin Lab Invest Suppl; 2016; 245():S6-S11. PubMed ID: 27426412
[TBL] [Abstract][Full Text] [Related]
18. UK’s adopts systematic approach to personalised cancer medicine.
Fricker J
Mol Oncol; 2011 Jun; 5(3):217-9. PubMed ID: 21774109
[No Abstract] [Full Text] [Related]
19. The value proposition of molecular medicine.
Waldman SA; Terzic A
Clin Transl Sci; 2012 Feb; 5(1):108-10. PubMed ID: 22376267
[No Abstract] [Full Text] [Related]
20. Data Science and Precision Oncology Nursing: Creating an Analytic Ecosystem to Support Personalized Supportive Care across the Trajectory of Illness.
Keim-Malpass J; Kausch SL
Semin Oncol Nurs; 2023 Jun; 39(3):151432. PubMed ID: 37149440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
